Skip to main content

New and competing renewal awards for September 2019

Friday, October 11, 2019
McGovern Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of September 2019. Please extend your congratulations to these individuals.

Patricia L. Ashley (Neonatology) received an award from Infant Bacterial Therapeutics AB in the amount of $97,748 for a research study entitled “A Randomized, Double Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500 - 1,500 Grams Birth Weight in the Prevention of Necrotizing Enterocolitis.” The project period is 09/01/2019 – 08/31/2021.

Mara L. Becker (Rheumatology) and Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $2,999,168 for a research study entitled “PTN2-TO#6 Clinical Pharmacokinetics and Safety Trials in Individuals with Down Syndrome.” The project period is 09/12/2019 – 09/11/2022.

Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $840,375 for a research study entitled “Pediatric Trials Network Task Order 1 Core Function Activities Options Period 1.” The project period is 06/04/2019 – 06/03/2020.

Daniel K. Benjamin, Jr. (Infectious Diseases) and Rachel G. Greenberg (Neonatology) received an award from National Institutes of Health in the amount of $19,452,198 for a research study entitled “HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement.” The project period is 09/26/2019 – 06/30/2023.

Michael Cohen-Wolkowiez (Infectious Diseases) received an award from National Institutes of Health in the amount of $1,135,117 for a research study entitled “PTN2-TO#4 Data Closeout and Dissemination Option Period 1.” The project period is 09/14/2019 – 09/13/2020.

Mai K. ElMallah (Pulmonary and Sleep Medicine) received an award from National Institutes of Health in the amount of $1,769,467 for a research study entitled “Targeted Therapy for Pompe Disease.” The project period is 09/12/2019 – 05/31/2024.

Christoph P. Hornik (Critical Care Medicine) received an award from National Institutes of Health in the amount of $1,128,112 for a research study entitled “PTN2-TO#3 Concept Development and Clinical Trial Readiness Support Option Period 1.” The project period is 09/14/2019 – 09/13/2020.

Christoph P. Hornik (Critical Care Medicine) received an award from National Institutes of Health in the amount of $775,149 for a research study entitled “Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia.” The project period is 09/15/2019 – 08/31/2021.

Corinne M. Linardic (Hematology-Oncology) and Christopher M. Counter (Pharmacology and Cancer Biology) received an award from National Institutes of Health in the amount of $5,849,947 for a research study entitled “Defining and Targeting the Molecular Vulnerabilities of the PAX3-FOXO1 Protein in Rhabdomyosarcoma.” The project period is 09/17/2019 – 08/31/2024. 

Michael A. Moody (Infectious Diseases) received an award from National Institutes of Health in the amount of $7,929,767 for a research study entitled “Collaborative Influenza Vaccine Innovation Centers Component A: Vaccine Center.” The project period is 08/01/2019 – 07/31/2026. 

Phillip B. Smith (Neonatology) and Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $6,750,000 for a research study entitled “ECHO Administrative Supplement – Neonatal Opioid Trials.” The project period is 09/23/2019 – 08/31/2020.

Phillip B. Smith (Neonatology) received an award from National Institutes of Health in the amount of $543,375 for a research study entitled “HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study.” The project period is 09/30/2019 – 03/31/2021.

Kanecia O. Zimmerman (Critical Care Medicine) received an award from National Institutes of Health in the amount of $8,472,460 for a research study entitled “PTN2-TO#5 BPCA Innovative Trial Designs for Dosing, Safety, and Efficacy in Pediatric Therapeutics.” The project period is 09/12/2019 – 02/28/2024.

Kanecia O. Zimmerman (Critical Care Medicine) received an award from U.S. Food and Drug Administration in the amount of $4,098,917 for a research study entitled “Clinical Outcome Assessments for Pediatric Opioid-Sparing Trials.” The project period is 09/10/2019 – 08/31/2024.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health